Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris Fox

Showing results (11-20 of 179) with videos related to

Pageof 18
Sort By:
British Dental Journal|May 8, 2010
Evidence summary: do people living in deprived areas define oral health differently from people who live in less deprived areas?Chris Fox, Helen Nield
Evidence-Based Medicine|May 15, 2014
Citalopram decreases agitation in the context of Alzheimer's disease, but at doses higher than those commonly prescribed and at the expense of side effectsBenjamin R Underwood, Chris Fox
Aviation, Space, and Environmental Medicine|December 25, 2003
Unexpected syncope and death during intense physical training: evolving role of molecular geneticsW Chris Fox, Warren Lockette
Medical Physics|April 22, 2009
Radiotherapy margin design with particular consideration of high curvature CTVsAlan Herschtal, Tomas Kron, Chris Fox
JAMA|November 29, 2007
Dementia screening in primary care: is it time?Carol Brayne, Chris Fox, Malaz Boustani
British Journal of Hospital Medicine (London, England : 2005)|August 18, 2009
Treatment of dementia: where is it going?Chris Fox, Malaz Boustani, Esme Moniz-Cook
International Journal of Geriatric Psychiatry|December 15, 2005
Drug treatment for Alzheimer's disease: the way forwardIan Maidment, Chris Fox, Gill Livingston, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|July 10, 2013
The pros and cons of early diagnosis in dementiaChris Fox, Louise Lafortune, Malaz Boustani, et al.
Hospital Practice (1995)|July 7, 2017
Implementing enhanced recovery pathways: a literature review with realist synthesisAstrid Coxon, Karina Nielsen, Jane Cross, et al.
The Cochrane Database of Systematic Reviews|March 16, 2012
Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's diseaseMichal Rolinski, Chris Fox, Ian Maidment, et al.
Pageof 18

Showing results (11-20 of 179) with videos related to

Sort By:
Pageof 18
British Dental Journal|May 8, 2010
Evidence summary: do people living in deprived areas define oral health differently from people who live in less deprived areas?Chris Fox, Helen Nield
Evidence-Based Medicine|May 15, 2014
Citalopram decreases agitation in the context of Alzheimer's disease, but at doses higher than those commonly prescribed and at the expense of side effectsBenjamin R Underwood, Chris Fox
Aviation, Space, and Environmental Medicine|December 25, 2003
Unexpected syncope and death during intense physical training: evolving role of molecular geneticsW Chris Fox, Warren Lockette
Medical Physics|April 22, 2009
Radiotherapy margin design with particular consideration of high curvature CTVsAlan Herschtal, Tomas Kron, Chris Fox
JAMA|November 29, 2007
Dementia screening in primary care: is it time?Carol Brayne, Chris Fox, Malaz Boustani
British Journal of Hospital Medicine (London, England : 2005)|August 18, 2009
Treatment of dementia: where is it going?Chris Fox, Malaz Boustani, Esme Moniz-Cook
International Journal of Geriatric Psychiatry|December 15, 2005
Drug treatment for Alzheimer's disease: the way forwardIan Maidment, Chris Fox, Gill Livingston, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|July 10, 2013
The pros and cons of early diagnosis in dementiaChris Fox, Louise Lafortune, Malaz Boustani, et al.
Hospital Practice (1995)|July 7, 2017
Implementing enhanced recovery pathways: a literature review with realist synthesisAstrid Coxon, Karina Nielsen, Jane Cross, et al.
The Cochrane Database of Systematic Reviews|March 16, 2012
Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's diseaseMichal Rolinski, Chris Fox, Ian Maidment, et al.
Pageof 18